The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
ZENITHDRUG Key Metrics
ZENITHDRUG Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
ZENITHDRUG Share Price
ZENITHDRUG
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ZENITHDRUG Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Low and declining ROE
Low and declining operating margin
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0650965.
Snapshot
See detailed analysis
ZENITHDRUG Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ZENITHDRUG Bulk, Block & Insider Trades
ZENITHDRUG Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tab... Read More
Key personnel
Mr. Neeraj Pandey
Chief Financial Officer
Ms. Sakshi Bhawsar
Company Secretary and Compliance Officer
Mr. Sandeep BhardwajD
Managing Director, Executive Director
Mr. Ajay Singh DassundiD
Executive Director
Mr. Bhupesh SoniD
Executive Director
Mr. Anil MalikD
Non-Executive Director
Mr. Deendayal KumawatD
Independent Non-Executive Director
Ms. Ranjana Sureshkumar SehgalD
Independent Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about ZENITHDRUG
The current share price of Zenith Drugs Ltd. is ₹ 41.10 as of 16 Jun 2026.
The Price-to-Earnings (PE) ratio of Zenith Drugs Ltd. is 17.88 as of the latest financial data.
Zenith Drugs Ltd. has a Return on Equity (ROE) of 5.46% and a Return on Capital Employed (ROCE) of 4.93% as per the latest financial reports.
The market capitalization of Zenith Drugs Ltd. stands at ₹ 70.48 Cr.
The dividend yield of Zenith Drugs Ltd. is 0.00% based on the current market price.
The Relative Strength Index (RSI) of Zenith Drugs Ltd. is 47.57.
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Zenith Drugs Ltd. shares.
Zenith Drugs Ltd. operates in the Healthcare sector.
The beta of Zenith Drugs Ltd. stock is 1.00, indicating its volatility relative to the broader market.
